TrialPloS one2018

Chronic obstructive pulmonary disease with short-acting inhaled pharmacotherapy increases the risk of prostate cancer: A two-stage database approach.

Hui-Wen Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.